nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefdinir—MPO—Calcipotriol—psoriasis	0.782	1	CbGbCtD
Cefdinir—MPO—IL23-mediated signaling events—IL19—psoriasis	0.00581	0.198	CbGpPWpGaD
Cefdinir—MPO—IL23-mediated signaling events—IL23R—psoriasis	0.00334	0.114	CbGpPWpGaD
Cefdinir—MPO—IL23-mediated signaling events—IL23A—psoriasis	0.00284	0.0965	CbGpPWpGaD
Cefdinir—MPO—IL23-mediated signaling events—IL17A—psoriasis	0.00133	0.0452	CbGpPWpGaD
Cefdinir—MPO—IL23-mediated signaling events—IL12B—psoriasis	0.00124	0.042	CbGpPWpGaD
Cefdinir—MPO—IL23-mediated signaling events—NFKBIA—psoriasis	0.000693	0.0236	CbGpPWpGaD
Cefdinir—MPO—IL23-mediated signaling events—NOS2—psoriasis	0.000693	0.0236	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—CAT—psoriasis	0.000602	0.0205	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—CRP—psoriasis	0.000588	0.02	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—APOE—psoriasis	0.000575	0.0196	CbGpPWpGaD
Cefdinir—MPO—IL23-mediated signaling events—TYK2—psoriasis	0.000568	0.0193	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—IL4—psoriasis	0.000553	0.0188	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—ICAM1—psoriasis	0.00054	0.0184	CbGpPWpGaD
Cefdinir—MPO—IL23-mediated signaling events—IFNG—psoriasis	0.000531	0.0181	CbGpPWpGaD
Cefdinir—MPO—IL23-mediated signaling events—CD4—psoriasis	0.000513	0.0174	CbGpPWpGaD
Cefdinir—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—psoriasis	0.000505	0.0172	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—CAT—psoriasis	0.000478	0.0163	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—CRP—psoriasis	0.000478	0.0163	CbGpPWpGaD
Cefdinir—MPO—IL23-mediated signaling events—NFKB1—psoriasis	0.000442	0.015	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—ICAM1—psoriasis	0.00044	0.0149	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—IFNG—psoriasis	0.000411	0.014	CbGpPWpGaD
Cefdinir—MPO—IL23-mediated signaling events—STAT3—psoriasis	0.000397	0.0135	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—CRP—psoriasis	0.00038	0.0129	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—ICAM1—psoriasis	0.000349	0.0119	CbGpPWpGaD
Cefdinir—MPO—IL23-mediated signaling events—TNF—psoriasis	0.000344	0.0117	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—NFKB1—psoriasis	0.000342	0.0116	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—IFNG—psoriasis	0.000334	0.0114	CbGpPWpGaD
Cefdinir—MPO—Folate Metabolism—NFKB1—psoriasis	0.000278	0.00946	CbGpPWpGaD
Cefdinir—MPO—IL23-mediated signaling events—IL6—psoriasis	0.000278	0.00943	CbGpPWpGaD
Cefdinir—MPO—C-MYB transcription factor network—CD4—psoriasis	0.000266	0.00905	CbGpPWpGaD
Cefdinir—MPO—Vitamin B12 Metabolism—TNF—psoriasis	0.000266	0.00904	CbGpPWpGaD
Cefdinir—MPO—Selenium Micronutrient Network—IFNG—psoriasis	0.000266	0.00903	CbGpPWpGaD
Cefdinir—SLC15A2—SLC-mediated transmembrane transport—CP—psoriasis	0.000252	0.00855	CbGpPWpGaD
Cefdinir—SLC15A1—SLC-mediated transmembrane transport—CP—psoriasis	0.000233	0.00794	CbGpPWpGaD
Cefdinir—Dyspepsia—Mycophenolic acid—psoriasis	0.00023	0.00122	CcSEcCtD
Cefdinir—Hypersensitivity—Hydroxyurea—psoriasis	0.00023	0.00122	CcSEcCtD
Cefdinir—Neutropenia—Prednisone—psoriasis	0.00023	0.00122	CcSEcCtD
Cefdinir—SLC22A5—SLC-mediated transmembrane transport—CP—psoriasis	0.00023	0.00781	CbGpPWpGaD
Cefdinir—Decreased appetite—Mycophenolic acid—psoriasis	0.000227	0.0012	CcSEcCtD
Cefdinir—Haemoglobin—Betamethasone—psoriasis	0.000227	0.0012	CcSEcCtD
Cefdinir—Haemoglobin—Dexamethasone—psoriasis	0.000227	0.0012	CcSEcCtD
Cefdinir—Leukopenia—Mycophenolate mofetil—psoriasis	0.000226	0.0012	CcSEcCtD
Cefdinir—Haemorrhage—Dexamethasone—psoriasis	0.000226	0.0012	CcSEcCtD
Cefdinir—Haemorrhage—Betamethasone—psoriasis	0.000226	0.0012	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Mycophenolic acid—psoriasis	0.000226	0.00119	CcSEcCtD
Cefdinir—Convulsion—Cyclosporine—psoriasis	0.000225	0.00119	CcSEcCtD
Cefdinir—Asthenia—Hydroxyurea—psoriasis	0.000224	0.00118	CcSEcCtD
Cefdinir—Hypertension—Cyclosporine—psoriasis	0.000224	0.00118	CcSEcCtD
Cefdinir—Constipation—Mycophenolic acid—psoriasis	0.000224	0.00118	CcSEcCtD
Cefdinir—Loss of consciousness—Mycophenolate mofetil—psoriasis	0.000222	0.00118	CcSEcCtD
Cefdinir—MPO—Selenium Micronutrient Network—NFKB1—psoriasis	0.000221	0.00751	CbGpPWpGaD
Cefdinir—Chest pain—Cyclosporine—psoriasis	0.000221	0.00117	CcSEcCtD
Cefdinir—Convulsion—Mycophenolate mofetil—psoriasis	0.000219	0.00116	CcSEcCtD
Cefdinir—Hypertension—Mycophenolate mofetil—psoriasis	0.000218	0.00115	CcSEcCtD
Cefdinir—MPO—Folate Metabolism—TNF—psoriasis	0.000216	0.00736	CbGpPWpGaD
Cefdinir—Acute coronary syndrome—Prednisone—psoriasis	0.000216	0.00114	CcSEcCtD
Cefdinir—Dry mouth—Cyclosporine—psoriasis	0.000216	0.00114	CcSEcCtD
Cefdinir—Chest pain—Mycophenolate mofetil—psoriasis	0.000215	0.00114	CcSEcCtD
Cefdinir—Myocardial infarction—Prednisone—psoriasis	0.000215	0.00114	CcSEcCtD
Cefdinir—MPO—Vitamin B12 Metabolism—IL6—psoriasis	0.000215	0.0073	CbGpPWpGaD
Cefdinir—Toxic epidermal necrolysis—Methotrexate—psoriasis	0.000214	0.00113	CcSEcCtD
Cefdinir—Gastrointestinal pain—Mycophenolic acid—psoriasis	0.000214	0.00113	CcSEcCtD
Cefdinir—Diarrhoea—Hydroxyurea—psoriasis	0.000214	0.00113	CcSEcCtD
Cefdinir—Anaphylactic shock—Cyclosporine—psoriasis	0.000212	0.00112	CcSEcCtD
Cefdinir—Dry mouth—Mycophenolate mofetil—psoriasis	0.000211	0.00111	CcSEcCtD
Cefdinir—Loss of consciousness—Prednisolone—psoriasis	0.000207	0.0011	CcSEcCtD
Cefdinir—Thrombocytopenia—Cyclosporine—psoriasis	0.000207	0.0011	CcSEcCtD
Cefdinir—Abdominal pain—Mycophenolic acid—psoriasis	0.000207	0.00109	CcSEcCtD
Cefdinir—Body temperature increased—Mycophenolic acid—psoriasis	0.000207	0.00109	CcSEcCtD
Cefdinir—Dizziness—Hydroxyurea—psoriasis	0.000207	0.00109	CcSEcCtD
Cefdinir—Anaphylactic shock—Mycophenolate mofetil—psoriasis	0.000206	0.00109	CcSEcCtD
Cefdinir—Asthma—Methotrexate—psoriasis	0.000206	0.00109	CcSEcCtD
Cefdinir—Convulsion—Prednisolone—psoriasis	0.000204	0.00108	CcSEcCtD
Cefdinir—Hypertension—Prednisolone—psoriasis	0.000204	0.00108	CcSEcCtD
Cefdinir—Shock—Mycophenolate mofetil—psoriasis	0.000203	0.00107	CcSEcCtD
Cefdinir—Loss of consciousness—Hydrocortisone—psoriasis	0.000203	0.00107	CcSEcCtD
Cefdinir—Thrombocytopenia—Mycophenolate mofetil—psoriasis	0.000202	0.00107	CcSEcCtD
Cefdinir—Anorexia—Cyclosporine—psoriasis	0.000202	0.00107	CcSEcCtD
Cefdinir—Convulsion—Hydrocortisone—psoriasis	0.0002	0.00106	CcSEcCtD
Cefdinir—Hypertension—Hydrocortisone—psoriasis	0.000199	0.00105	CcSEcCtD
Cefdinir—Vomiting—Hydroxyurea—psoriasis	0.000199	0.00105	CcSEcCtD
Cefdinir—Haemoglobin—Prednisone—psoriasis	0.000198	0.00105	CcSEcCtD
Cefdinir—Haemorrhage—Prednisone—psoriasis	0.000197	0.00104	CcSEcCtD
Cefdinir—Rash—Hydroxyurea—psoriasis	0.000197	0.00104	CcSEcCtD
Cefdinir—Anorexia—Mycophenolate mofetil—psoriasis	0.000197	0.00104	CcSEcCtD
Cefdinir—Dermatitis—Hydroxyurea—psoriasis	0.000197	0.00104	CcSEcCtD
Cefdinir—Headache—Hydroxyurea—psoriasis	0.000196	0.00103	CcSEcCtD
Cefdinir—Pancytopenia—Methotrexate—psoriasis	0.000195	0.00103	CcSEcCtD
Cefdinir—Anaphylactic shock—Prednisolone—psoriasis	0.000193	0.00102	CcSEcCtD
Cefdinir—Neutropenia—Methotrexate—psoriasis	0.000192	0.00102	CcSEcCtD
Cefdinir—Insomnia—Cyclosporine—psoriasis	0.000191	0.00101	CcSEcCtD
Cefdinir—MPO—Folate Metabolism—TP53—psoriasis	0.000191	0.00649	CbGpPWpGaD
Cefdinir—Loss of consciousness—Triamcinolone—psoriasis	0.000191	0.00101	CcSEcCtD
Cefdinir—Shock—Prednisolone—psoriasis	0.000189	0.001	CcSEcCtD
Cefdinir—Somnolence—Cyclosporine—psoriasis	0.000188	0.000995	CcSEcCtD
Cefdinir—Anaphylactic shock—Hydrocortisone—psoriasis	0.000188	0.000994	CcSEcCtD
Cefdinir—Convulsion—Triamcinolone—psoriasis	0.000188	0.000994	CcSEcCtD
Cefdinir—Asthenia—Mycophenolic acid—psoriasis	0.000188	0.000992	CcSEcCtD
Cefdinir—Hypertension—Triamcinolone—psoriasis	0.000187	0.000991	CcSEcCtD
Cefdinir—Insomnia—Mycophenolate mofetil—psoriasis	0.000187	0.000987	CcSEcCtD
Cefdinir—Dyspepsia—Cyclosporine—psoriasis	0.000186	0.000985	CcSEcCtD
Cefdinir—Nausea—Hydroxyurea—psoriasis	0.000186	0.000981	CcSEcCtD
Cefdinir—Pruritus—Mycophenolic acid—psoriasis	0.000185	0.000979	CcSEcCtD
Cefdinir—Shock—Hydrocortisone—psoriasis	0.000185	0.000978	CcSEcCtD
Cefdinir—Pneumonia—Methotrexate—psoriasis	0.000184	0.000975	CcSEcCtD
Cefdinir—Decreased appetite—Cyclosporine—psoriasis	0.000184	0.000973	CcSEcCtD
Cefdinir—Somnolence—Mycophenolate mofetil—psoriasis	0.000184	0.00097	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Cyclosporine—psoriasis	0.000183	0.000966	CcSEcCtD
Cefdinir—Stevens-Johnson syndrome—Methotrexate—psoriasis	0.000182	0.000961	CcSEcCtD
Cefdinir—Dyspepsia—Mycophenolate mofetil—psoriasis	0.000182	0.000961	CcSEcCtD
Cefdinir—Constipation—Cyclosporine—psoriasis	0.000181	0.000957	CcSEcCtD
Cefdinir—Dry mouth—Triamcinolone—psoriasis	0.000181	0.000955	CcSEcCtD
Cefdinir—Renal failure—Methotrexate—psoriasis	0.00018	0.000953	CcSEcCtD
Cefdinir—Decreased appetite—Mycophenolate mofetil—psoriasis	0.000179	0.000949	CcSEcCtD
Cefdinir—Anorexia—Hydrocortisone—psoriasis	0.000179	0.000948	CcSEcCtD
Cefdinir—Diarrhoea—Mycophenolic acid—psoriasis	0.000179	0.000946	CcSEcCtD
Cefdinir—Stomatitis—Methotrexate—psoriasis	0.000179	0.000945	CcSEcCtD
Cefdinir—Conjunctivitis—Methotrexate—psoriasis	0.000178	0.000942	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	0.000178	0.000942	CcSEcCtD
Cefdinir—Anaphylactic shock—Triamcinolone—psoriasis	0.000177	0.000936	CcSEcCtD
Cefdinir—Constipation—Mycophenolate mofetil—psoriasis	0.000177	0.000933	CcSEcCtD
Cefdinir—Haematuria—Methotrexate—psoriasis	0.000175	0.000924	CcSEcCtD
Cefdinir—MPO—Folate Metabolism—IL6—psoriasis	0.000175	0.00594	CbGpPWpGaD
Cefdinir—Shock—Triamcinolone—psoriasis	0.000174	0.000921	CcSEcCtD
Cefdinir—Insomnia—Prednisolone—psoriasis	0.000174	0.000921	CcSEcCtD
Cefdinir—Gastrointestinal pain—Cyclosporine—psoriasis	0.000173	0.000915	CcSEcCtD
Cefdinir—Loss of consciousness—Dexamethasone—psoriasis	0.000173	0.000915	CcSEcCtD
Cefdinir—Loss of consciousness—Betamethasone—psoriasis	0.000173	0.000915	CcSEcCtD
Cefdinir—Dizziness—Mycophenolic acid—psoriasis	0.000173	0.000915	CcSEcCtD
Cefdinir—MPO—Selenium Micronutrient Network—TNF—psoriasis	0.000172	0.00585	CbGpPWpGaD
Cefdinir—Agranulocytosis—Methotrexate—psoriasis	0.000171	0.000905	CcSEcCtD
Cefdinir—Convulsion—Betamethasone—psoriasis	0.000171	0.000902	CcSEcCtD
Cefdinir—Convulsion—Dexamethasone—psoriasis	0.000171	0.000902	CcSEcCtD
Cefdinir—Insomnia—Hydrocortisone—psoriasis	0.00017	0.000899	CcSEcCtD
Cefdinir—Hypertension—Dexamethasone—psoriasis	0.00017	0.000899	CcSEcCtD
Cefdinir—Hypertension—Betamethasone—psoriasis	0.00017	0.000899	CcSEcCtD
Cefdinir—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	0.000169	0.000893	CcSEcCtD
Cefdinir—Abdominal pain—Cyclosporine—psoriasis	0.000167	0.000885	CcSEcCtD
Cefdinir—Body temperature increased—Cyclosporine—psoriasis	0.000167	0.000885	CcSEcCtD
Cefdinir—Vomiting—Mycophenolic acid—psoriasis	0.000166	0.000879	CcSEcCtD
Cefdinir—Dyspepsia—Hydrocortisone—psoriasis	0.000166	0.000875	CcSEcCtD
Cefdinir—Haemoglobin—Methotrexate—psoriasis	0.000165	0.000875	CcSEcCtD
Cefdinir—Rash—Mycophenolic acid—psoriasis	0.000165	0.000872	CcSEcCtD
Cefdinir—Dermatitis—Mycophenolic acid—psoriasis	0.000165	0.000871	CcSEcCtD
Cefdinir—Haemorrhage—Methotrexate—psoriasis	0.000165	0.00087	CcSEcCtD
Cefdinir—Headache—Mycophenolic acid—psoriasis	0.000164	0.000867	CcSEcCtD
Cefdinir—Decreased appetite—Hydrocortisone—psoriasis	0.000163	0.000865	CcSEcCtD
Cefdinir—Abdominal pain—Mycophenolate mofetil—psoriasis	0.000163	0.000863	CcSEcCtD
Cefdinir—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000163	0.000863	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.000162	0.000859	CcSEcCtD
Cefdinir—Anaphylactic shock—Betamethasone—psoriasis	0.000161	0.00085	CcSEcCtD
Cefdinir—Anaphylactic shock—Dexamethasone—psoriasis	0.000161	0.00085	CcSEcCtD
Cefdinir—Insomnia—Triamcinolone—psoriasis	0.00016	0.000847	CcSEcCtD
Cefdinir—Shock—Dexamethasone—psoriasis	0.000158	0.000836	CcSEcCtD
Cefdinir—Shock—Betamethasone—psoriasis	0.000158	0.000836	CcSEcCtD
Cefdinir—Agitation—Prednisone—psoriasis	0.000158	0.000833	CcSEcCtD
Cefdinir—Thrombocytopenia—Dexamethasone—psoriasis	0.000157	0.000832	CcSEcCtD
Cefdinir—Thrombocytopenia—Betamethasone—psoriasis	0.000157	0.000832	CcSEcCtD
Cefdinir—Hypersensitivity—Cyclosporine—psoriasis	0.000156	0.000824	CcSEcCtD
Cefdinir—Dyspepsia—Triamcinolone—psoriasis	0.000156	0.000824	CcSEcCtD
Cefdinir—Erythema multiforme—Methotrexate—psoriasis	0.000156	0.000823	CcSEcCtD
Cefdinir—Nausea—Mycophenolic acid—psoriasis	0.000155	0.000822	CcSEcCtD
Cefdinir—Gastrointestinal pain—Hydrocortisone—psoriasis	0.000154	0.000813	CcSEcCtD
Cefdinir—Anorexia—Dexamethasone—psoriasis	0.000153	0.00081	CcSEcCtD
Cefdinir—Anorexia—Betamethasone—psoriasis	0.000153	0.00081	CcSEcCtD
Cefdinir—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.000152	0.000804	CcSEcCtD
Cefdinir—Asthenia—Cyclosporine—psoriasis	0.000152	0.000803	CcSEcCtD
Cefdinir—Loss of consciousness—Prednisone—psoriasis	0.000151	0.000797	CcSEcCtD
Cefdinir—Pruritus—Cyclosporine—psoriasis	0.00015	0.000792	CcSEcCtD
Cefdinir—Body temperature increased—Hydrocortisone—psoriasis	0.000149	0.000786	CcSEcCtD
Cefdinir—Abdominal pain—Hydrocortisone—psoriasis	0.000149	0.000786	CcSEcCtD
Cefdinir—Convulsion—Prednisone—psoriasis	0.000149	0.000786	CcSEcCtD
Cefdinir—Asthenia—Mycophenolate mofetil—psoriasis	0.000148	0.000783	CcSEcCtD
Cefdinir—Hypertension—Prednisone—psoriasis	0.000148	0.000783	CcSEcCtD
Cefdinir—Pruritus—Mycophenolate mofetil—psoriasis	0.000146	0.000772	CcSEcCtD
Cefdinir—Insomnia—Dexamethasone—psoriasis	0.000145	0.000768	CcSEcCtD
Cefdinir—Insomnia—Betamethasone—psoriasis	0.000145	0.000768	CcSEcCtD
Cefdinir—Diarrhoea—Cyclosporine—psoriasis	0.000145	0.000766	CcSEcCtD
Cefdinir—Hypersensitivity—Prednisolone—psoriasis	0.000142	0.00075	CcSEcCtD
Cefdinir—Dyspepsia—Dexamethasone—psoriasis	0.000141	0.000748	CcSEcCtD
Cefdinir—Dyspepsia—Betamethasone—psoriasis	0.000141	0.000748	CcSEcCtD
Cefdinir—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000141	0.000747	CcSEcCtD
Cefdinir—Body temperature increased—Triamcinolone—psoriasis	0.00014	0.00074	CcSEcCtD
Cefdinir—Dizziness—Cyclosporine—psoriasis	0.00014	0.00074	CcSEcCtD
Cefdinir—Anaphylactic shock—Prednisone—psoriasis	0.00014	0.00074	CcSEcCtD
Cefdinir—Decreased appetite—Dexamethasone—psoriasis	0.00014	0.000739	CcSEcCtD
Cefdinir—Decreased appetite—Betamethasone—psoriasis	0.00014	0.000739	CcSEcCtD
Cefdinir—MPO—Selenium Micronutrient Network—IL6—psoriasis	0.000139	0.00472	CbGpPWpGaD
Cefdinir—Gastrointestinal disorder—Dexamethasone—psoriasis	0.000139	0.000734	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Betamethasone—psoriasis	0.000139	0.000734	CcSEcCtD
Cefdinir—Hypersensitivity—Hydrocortisone—psoriasis	0.000139	0.000733	CcSEcCtD
Cefdinir—Shock—Prednisone—psoriasis	0.000138	0.000728	CcSEcCtD
Cefdinir—Dizziness—Mycophenolate mofetil—psoriasis	0.000137	0.000722	CcSEcCtD
Cefdinir—Asthenia—Hydrocortisone—psoriasis	0.000135	0.000714	CcSEcCtD
Cefdinir—Vomiting—Cyclosporine—psoriasis	0.000135	0.000711	CcSEcCtD
Cefdinir—Rash—Cyclosporine—psoriasis	0.000133	0.000706	CcSEcCtD
Cefdinir—Anorexia—Prednisone—psoriasis	0.000133	0.000705	CcSEcCtD
Cefdinir—Dermatitis—Cyclosporine—psoriasis	0.000133	0.000705	CcSEcCtD
Cefdinir—Pruritus—Hydrocortisone—psoriasis	0.000133	0.000704	CcSEcCtD
Cefdinir—Headache—Cyclosporine—psoriasis	0.000133	0.000701	CcSEcCtD
Cefdinir—Gastrointestinal pain—Betamethasone—psoriasis	0.000131	0.000695	CcSEcCtD
Cefdinir—Gastrointestinal pain—Dexamethasone—psoriasis	0.000131	0.000695	CcSEcCtD
Cefdinir—Vomiting—Mycophenolate mofetil—psoriasis	0.000131	0.000694	CcSEcCtD
Cefdinir—Hypersensitivity—Triamcinolone—psoriasis	0.00013	0.00069	CcSEcCtD
Cefdinir—Rash—Mycophenolate mofetil—psoriasis	0.00013	0.000688	CcSEcCtD
Cefdinir—Dermatitis—Mycophenolate mofetil—psoriasis	0.00013	0.000688	CcSEcCtD
Cefdinir—Headache—Mycophenolate mofetil—psoriasis	0.000129	0.000684	CcSEcCtD
Cefdinir—Diarrhoea—Hydrocortisone—psoriasis	0.000129	0.00068	CcSEcCtD
Cefdinir—Leukopenia—Methotrexate—psoriasis	0.000128	0.000678	CcSEcCtD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—CP—psoriasis	0.000128	0.00435	CbGpPWpGaD
Cefdinir—Dizziness—Prednisolone—psoriasis	0.000127	0.000673	CcSEcCtD
Cefdinir—Asthenia—Triamcinolone—psoriasis	0.000127	0.000672	CcSEcCtD
Cefdinir—Abdominal pain—Dexamethasone—psoriasis	0.000127	0.000672	CcSEcCtD
Cefdinir—Abdominal pain—Betamethasone—psoriasis	0.000127	0.000672	CcSEcCtD
Cefdinir—Body temperature increased—Dexamethasone—psoriasis	0.000127	0.000672	CcSEcCtD
Cefdinir—Body temperature increased—Betamethasone—psoriasis	0.000127	0.000672	CcSEcCtD
Cefdinir—Insomnia—Prednisone—psoriasis	0.000127	0.000669	CcSEcCtD
Cefdinir—Nausea—Cyclosporine—psoriasis	0.000126	0.000665	CcSEcCtD
Cefdinir—Pruritus—Triamcinolone—psoriasis	0.000125	0.000663	CcSEcCtD
Cefdinir—Dizziness—Hydrocortisone—psoriasis	0.000124	0.000658	CcSEcCtD
Cefdinir—Convulsion—Methotrexate—psoriasis	0.000124	0.000656	CcSEcCtD
Cefdinir—Dyspepsia—Prednisone—psoriasis	0.000123	0.000651	CcSEcCtD
Cefdinir—Nausea—Mycophenolate mofetil—psoriasis	0.000123	0.000648	CcSEcCtD
Cefdinir—Chest pain—Methotrexate—psoriasis	0.000122	0.000645	CcSEcCtD
Cefdinir—SLC15A2—Transmembrane transport of small molecules—CARM1—psoriasis	0.000122	0.00415	CbGpPWpGaD
Cefdinir—Decreased appetite—Prednisone—psoriasis	0.000122	0.000643	CcSEcCtD
Cefdinir—Rash—Prednisolone—psoriasis	0.000121	0.000642	CcSEcCtD
Cefdinir—Dermatitis—Prednisolone—psoriasis	0.000121	0.000641	CcSEcCtD
Cefdinir—Headache—Prednisolone—psoriasis	0.000121	0.000638	CcSEcCtD
Cefdinir—Constipation—Prednisone—psoriasis	0.00012	0.000633	CcSEcCtD
Cefdinir—Vomiting—Hydrocortisone—psoriasis	0.00012	0.000632	CcSEcCtD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—CP—psoriasis	0.000119	0.00403	CbGpPWpGaD
Cefdinir—Rash—Hydrocortisone—psoriasis	0.000119	0.000627	CcSEcCtD
Cefdinir—Dermatitis—Hydrocortisone—psoriasis	0.000118	0.000626	CcSEcCtD
Cefdinir—Headache—Hydrocortisone—psoriasis	0.000118	0.000623	CcSEcCtD
Cefdinir—Dizziness—Triamcinolone—psoriasis	0.000117	0.000619	CcSEcCtD
Cefdinir—Anaphylactic shock—Methotrexate—psoriasis	0.000117	0.000618	CcSEcCtD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—CP—psoriasis	0.000117	0.00397	CbGpPWpGaD
Cefdinir—Asthenia—Dexamethasone—psoriasis	0.000115	0.00061	CcSEcCtD
Cefdinir—Asthenia—Betamethasone—psoriasis	0.000115	0.00061	CcSEcCtD
Cefdinir—Thrombocytopenia—Methotrexate—psoriasis	0.000115	0.000605	CcSEcCtD
Cefdinir—Gastrointestinal pain—Prednisone—psoriasis	0.000114	0.000605	CcSEcCtD
Cefdinir—Nausea—Prednisolone—psoriasis	0.000114	0.000605	CcSEcCtD
Cefdinir—Pruritus—Dexamethasone—psoriasis	0.000114	0.000601	CcSEcCtD
Cefdinir—Pruritus—Betamethasone—psoriasis	0.000114	0.000601	CcSEcCtD
Cefdinir—SLC15A1—Transmembrane transport of small molecules—CARM1—psoriasis	0.000113	0.00385	CbGpPWpGaD
Cefdinir—Vomiting—Triamcinolone—psoriasis	0.000113	0.000595	CcSEcCtD
Cefdinir—Nausea—Hydrocortisone—psoriasis	0.000112	0.000591	CcSEcCtD
Cefdinir—Rash—Triamcinolone—psoriasis	0.000112	0.00059	CcSEcCtD
Cefdinir—Dermatitis—Triamcinolone—psoriasis	0.000112	0.00059	CcSEcCtD
Cefdinir—Anorexia—Methotrexate—psoriasis	0.000111	0.000589	CcSEcCtD
Cefdinir—SLC22A5—Transmembrane transport of small molecules—CARM1—psoriasis	0.000111	0.00378	CbGpPWpGaD
Cefdinir—Headache—Triamcinolone—psoriasis	0.000111	0.000587	CcSEcCtD
Cefdinir—Body temperature increased—Prednisone—psoriasis	0.000111	0.000585	CcSEcCtD
Cefdinir—Abdominal pain—Prednisone—psoriasis	0.000111	0.000585	CcSEcCtD
Cefdinir—Diarrhoea—Dexamethasone—psoriasis	0.00011	0.000581	CcSEcCtD
Cefdinir—Diarrhoea—Betamethasone—psoriasis	0.00011	0.000581	CcSEcCtD
Cefdinir—Dizziness—Dexamethasone—psoriasis	0.000106	0.000562	CcSEcCtD
Cefdinir—Dizziness—Betamethasone—psoriasis	0.000106	0.000562	CcSEcCtD
Cefdinir—Insomnia—Methotrexate—psoriasis	0.000106	0.000559	CcSEcCtD
Cefdinir—Nausea—Triamcinolone—psoriasis	0.000105	0.000556	CcSEcCtD
Cefdinir—Somnolence—Methotrexate—psoriasis	0.000104	0.00055	CcSEcCtD
Cefdinir—Hypersensitivity—Prednisone—psoriasis	0.000103	0.000545	CcSEcCtD
Cefdinir—Dyspepsia—Methotrexate—psoriasis	0.000103	0.000544	CcSEcCtD
Cefdinir—Vomiting—Betamethasone—psoriasis	0.000102	0.00054	CcSEcCtD
Cefdinir—Vomiting—Dexamethasone—psoriasis	0.000102	0.00054	CcSEcCtD
Cefdinir—Decreased appetite—Methotrexate—psoriasis	0.000102	0.000538	CcSEcCtD
Cefdinir—Rash—Betamethasone—psoriasis	0.000101	0.000536	CcSEcCtD
Cefdinir—Rash—Dexamethasone—psoriasis	0.000101	0.000536	CcSEcCtD
Cefdinir—Dermatitis—Dexamethasone—psoriasis	0.000101	0.000535	CcSEcCtD
Cefdinir—Dermatitis—Betamethasone—psoriasis	0.000101	0.000535	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Methotrexate—psoriasis	0.000101	0.000534	CcSEcCtD
Cefdinir—Headache—Betamethasone—psoriasis	0.000101	0.000532	CcSEcCtD
Cefdinir—Headache—Dexamethasone—psoriasis	0.000101	0.000532	CcSEcCtD
Cefdinir—Asthenia—Prednisone—psoriasis	0.0001	0.000531	CcSEcCtD
Cefdinir—Pruritus—Prednisone—psoriasis	9.9e-05	0.000524	CcSEcCtD
Cefdinir—Diarrhoea—Prednisone—psoriasis	9.57e-05	0.000506	CcSEcCtD
Cefdinir—Gastrointestinal pain—Methotrexate—psoriasis	9.56e-05	0.000506	CcSEcCtD
Cefdinir—Nausea—Betamethasone—psoriasis	9.54e-05	0.000505	CcSEcCtD
Cefdinir—Nausea—Dexamethasone—psoriasis	9.54e-05	0.000505	CcSEcCtD
Cefdinir—Dizziness—Prednisone—psoriasis	9.25e-05	0.000489	CcSEcCtD
Cefdinir—Body temperature increased—Methotrexate—psoriasis	9.24e-05	0.000489	CcSEcCtD
Cefdinir—Abdominal pain—Methotrexate—psoriasis	9.24e-05	0.000489	CcSEcCtD
Cefdinir—Vomiting—Prednisone—psoriasis	8.9e-05	0.00047	CcSEcCtD
Cefdinir—Rash—Prednisone—psoriasis	8.82e-05	0.000467	CcSEcCtD
Cefdinir—Dermatitis—Prednisone—psoriasis	8.82e-05	0.000466	CcSEcCtD
Cefdinir—Headache—Prednisone—psoriasis	8.77e-05	0.000464	CcSEcCtD
Cefdinir—Hypersensitivity—Methotrexate—psoriasis	8.62e-05	0.000456	CcSEcCtD
Cefdinir—Asthenia—Methotrexate—psoriasis	8.39e-05	0.000444	CcSEcCtD
Cefdinir—Nausea—Prednisone—psoriasis	8.31e-05	0.00044	CcSEcCtD
Cefdinir—Pruritus—Methotrexate—psoriasis	8.27e-05	0.000438	CcSEcCtD
Cefdinir—Diarrhoea—Methotrexate—psoriasis	8e-05	0.000423	CcSEcCtD
Cefdinir—Dizziness—Methotrexate—psoriasis	7.73e-05	0.000409	CcSEcCtD
Cefdinir—Vomiting—Methotrexate—psoriasis	7.44e-05	0.000393	CcSEcCtD
Cefdinir—Rash—Methotrexate—psoriasis	7.37e-05	0.00039	CcSEcCtD
Cefdinir—Dermatitis—Methotrexate—psoriasis	7.37e-05	0.00039	CcSEcCtD
Cefdinir—Headache—Methotrexate—psoriasis	7.33e-05	0.000387	CcSEcCtD
Cefdinir—Nausea—Methotrexate—psoriasis	6.95e-05	0.000367	CcSEcCtD
